1105062-42-7 Usage
Heterocyclic compound
It contains both pyridine and imidazole rings This means that the compound has a ring structure containing both carbon and nitrogen atoms, which can affect its chemical properties and reactivity.
Structural features
Contains pyridine and imidazole rings The presence of these specific ring structures may contribute to the compound's potential biological activity and applications in pharmaceutical research.
Potential applications
Pharmaceutical research and drug development Due to its unique structure, 2-(2-pyridinyl)-5H-imidazo[4,5-d]pyridazine may have properties that make it useful in the creation of new medications or therapies.
Synthesis and handling requirements
Specific synthesis and handling may be needed The compound's chemical properties may require special procedures for its preparation and use, which could impact its practical applications.
Further research
More studies needed to understand potential uses and limitations As with any new compound, additional research is necessary to fully explore the capabilities and constraints of 2-(2-pyridinyl)-5H-imidazo[4,5-d]pyridazine in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1105062-42-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,0,6 and 2 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1105062-42:
(9*1)+(8*1)+(7*0)+(6*5)+(5*0)+(4*6)+(3*2)+(2*4)+(1*2)=87
87 % 10 = 7
So 1105062-42-7 is a valid CAS Registry Number.
1105062-42-7Relevant articles and documents
Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them
-
Page/Page column 83, (2010/03/02)
Disclosed are processes for the preparation of compounds of formula I and compositions that comprise said compounds of formula I. Also disclosed are processes for the preparation of compounds of formula III and compositions that comprise said compounds of formula III.
